The role of the bidirectional regulatory network between immune cells and stromal cells in cardiac repair and fibrosis following myocardial infarction - Report - MDSpire

The role of the bidirectional regulatory network between immune cells and stromal cells in cardiac repair and fibrosis following myocardial infarction

  • By

  • Fuyuan Zhang

  • Yiying Liu

  • Ruikang Liu

  • Baohua Li

  • Jun Li

  • June 17, 2026

  • 0 min

Share

Clinical Report: The Interplay Between Immune and Stromal Cells in Cardiac Repair

Overview

This review explores the complex interactions between immune and stromal cells in cardiac repair and fibrosis following myocardial infarction (MI). It highlights the dynamic communication pathways that govern inflammation and fibrosis.

Background

Heart failure post-myocardial infarction is a significant complication that adversely affects patient prognosis. Understanding the mechanisms of cardiac repair and the role of immune and stromal cells is crucial.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Cardiac repair after MI involves a dynamic bidirectional interaction between immune cells and cardiac stromal cells.
  • Key immune cells include neutrophils, macrophages, and lymphocytes, which communicate with stromal cells such as fibroblasts and endothelial cells.
  • The review maps the spatiotemporal evolution of these interactions.
  • Imbalances in the immune-stromal network can lead to pathological fibrosis and heart failure.

Clinical Implications

Healthcare professionals should consider the interactions between immune and stromal cells when evaluating cardiac repair processes post-MI.

Conclusion

The intricate interplay between immune and stromal cells is vital for cardiac repair after MI.

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- Targeting the heart-immune axis after myocardial infarction: from inflammation to immunomodulation
  2. Basic Research in Cardiology, 2022 -- The Importance of Endothelial Resilience in Sustaining Cardiac Health
  3. Basic Research in Cardiology, 2018 -- Targeting Inflammatory Cells and Their Non-Coding RNAs for Myocardial Infarction Treatment
  4. Basic Research in Cardiology, 2020 -- Non-coding RNAs: Key Contributors to Cardiomyocyte Growth and Cardiac Repair
  5. Hub - 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
  6. Colchicine in Acute Myocardial Infarction | New England Journal of Medicine
  7. Hub - 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
  8. Colchicine in Acute Myocardial Infarction | New England Journal of Medicine

Original Source(s)

Related Content